CJC-1295 (no DAC), Ipamorelin 10mg (Blend)

CJC-1295 (no DAC) and Ipamorelin are synthetic peptides commonly paired together due to their complementary effects on growth hormone (GH) release. When used as a blend, they are intended to stimulate the body’s natural production of growth hormone in a more controlled and physiologic way rather than replacing it directly. This combination is widely discussed in research and wellness communities, though it is not approved as a medical treatment.

What CJC-1295 (No DAC) Is

CJC-1295 (no DAC) is a modified version of growth hormone–releasing hormone (GHRH). Its role is to signal the pituitary gland to increase the amplitude of growth hormone pulses. The “no DAC” version is short-acting, meaning it stays active in the body for a relatively brief period and is designed to more closely mimic the body’s natural GH rhythm.

Because it does not remain active for extended periods, CJC-1295 (no DAC) is often associated with a more natural pattern of GH secretion rather than prolonged elevation.

What Ipamorelin Is

Ipamorelin is a growth hormone secretagogue that works through a different pathway than CJC-1295. It mimics the action of ghrelin, a hormone involved in growth hormone release. Ipamorelin primarily increases the frequency of GH pulses rather than their size.

One reason Ipamorelin receives attention is its relative selectivity. It is often described as stimulating growth hormone with minimal impact on other hormones such as cortisol or prolactin, which are sometimes affected by older GH-releasing compounds.

How the Blend Works

When combined, CJC-1295 (no DAC) and Ipamorelin are intended to work synergistically. CJC-1295 increases how much growth hormone is released per pulse, while Ipamorelin encourages the pulses to occur more often. Together, this may lead to a more robust but still physiologic increase in overall growth hormone output.

Rather than forcing continuous hormone elevation, the blend is designed to support the body’s own signaling mechanisms, aligning more closely with natural endocrine rhythms.

Potential Areas of Interest

The CJC-1295 and Ipamorelin blend is commonly associated with research into:

• Growth hormone and IGF-1 support

• Muscle recovery and repair

• Body composition changes

• Sleep quality and recovery

• Skin, hair, and connective tissue health

• General wellness and aging-related research

These effects are based on the known role of growth hormone in the body, as well as early studies and anecdotal observations, not established clinical outcomes.